Used as a key intermediate in the synthesis of biologically active peptides and peptidomimetics, particularly in the development of pharmaceuticals where stereochemistry plays a critical role. The presence of the fluorenylmethyloxycarbonyl (Fmoc) protecting group makes it suitable for solid-phase peptide synthesis (SPPS), allowing for stepwise assembly of peptide chains under mild conditions. The fluorinated aromatic side chain enhances binding selectivity in receptor-targeted drug candidates, especially in central nervous system agents and enzyme inhibitors. Its chiral center ensures high enantiomeric purity in final products, which is essential for optimizing pharmacological activity and reducing off-target effects.